eferred treatment regimen for patients who fail frontline therapy in CLL

eferred treatment regimen for patients who fail frontline therapy in CLL

ScrippsHealth

4 years
374 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Susan M. O'Brien , MD of University of California Irvine the preferred treatment regimen for patients who fail frontline therapy in CLL at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego. www.scrippshealth.org/cancer
Up Next Autoplay